[Ortho] ScienceDirect Alert: Joint Bone Spine, Vol. 75, Supp. 1, 2008

Сб Авг 16 21:37:42 YEKST 2008

New Volume/Issue is now available on ScienceDirect!

*  Joint Bone Spine
   Volume 75, Supplement 1, Pages S2-S99 (June 2008)
   Rituximab (MabThera®) therapy and safety management
   http://www.sciencedirect.com/science/issue/6668-2008-999249999.8998-696064

NOTE: If the URLs in this email are not active hyperlinks, copy and paste the URL into the address/location box in your browser.

================================================================================
TABLE OF CONTENTS

================================================================================
   Editorial
================================================================================
1) Editorial
Page S2
Xavier Mariette, Thao Pham and Jean Sibilia
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-1&md5=56f9f7033c5bdf7f7073ff5dc5be8a8d

2) Initial pre-treatment assessment
Page S4
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-2&md5=4e2e3016a6e7ca6c87bc205cb72882c0

3) Initial rituximab treatment in patients with RA: clinical, laboratory, and radiological monitoring
Pages S5-S7
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-3&md5=3227ba742c7acc412b2fc70e033ff489

4) Rituximab re-treatment in patients with RA
Pages S8-S14
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-4&md5=034643572d3c0d953647ccf314f93cb4

5) Main symptoms to monitor during rituximab therapy and diagnostic orientation
Pages S15-S16
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-5&md5=26d5a55cc690befc816dea06f8ce9421

6) Management of patients with past or present bacterial and/or viral infections
Pages S17-S21
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-6&md5=d9e700a3ca2403f27364a5e21f108bdd

7) Management of patients with past or solid cancer
Pages S22-S28
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-7&md5=fe1f9dd0f8230892023753c61ee3937d

8) Management of patients with past or present lymphoma or other haematological disease
Pages S29-S31
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-8&md5=ebd5ed0fe5c6b81241b8dcd09481e575

9) Management of Patients with Past or Present Cardiovascular Disease
Pages S32-S33
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-9&md5=041ba83caedd72a9916ffc0c21b44f52

10) Management of patients with past or present central nervous system disease
Pages S34-S38
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-B&md5=7d1ff3ea0caac00856ce5d8d227b8daf

11) Management of patients with past or present infusion-related reactions: immediate and delayed intolerance
Pages S39-S41
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-C&md5=78c8ecb1b08c2ecf1464b75fbffa1ae2

12) Management of patients who are pregnant
Pages S42-S46
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-D&md5=3e5a0d8649e4eefdaaaa604365ca8ae3

13) Vaccinations in rituximab-treated patients
Pages S47-S50
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-F&md5=f5c0a294d4187f5b944490938e0f5a44

14) Management of patients who plan to travel
Page S51
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-G&md5=6ceaa952db0161b4ad3d091124f12439

15) Management of patients who require surgery
Pages S52-S54
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-H&md5=51b46da20a3f4a88a713ae82bc114778

16) Management of patients who require corticosteroid therapy
Page S55
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-J&md5=e29026cb873acdb7164d15240f10ab67

17) Management of drug-drug interactions
Pages S56-S57
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-K&md5=dc4f034707cd71c9d2330fe884dd163f

18) Model information letter for an office-based rheumatologist
Pages S58-S61
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-M&md5=b530235cc245a1fcc2f03e97f4b45144

19) Model information letter for the primary-care physician
Pages S62-S64
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-N&md5=df0478d9a9b0b3651e81d130abd783ec

20) Using rituximab (MabThera®) to treat rheumatoid arthritis
Pages S65-S69
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-P&md5=898ce5cf6f430339b9d04d4893fcaa96

21) Using rituximab (MabThera®) to treat patients with systemic lupus erythematosus
Pages S70-S80
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-R&md5=69dfc84ef0aac15f2a70d3768fb976ed

22) Rituximab (MabThera®) therapy in patients with systemic vasculitides
Pages S81-S93
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-S&md5=5ceca1d35c718826d78fad5e5509a255

23) Using rituximab (MabThera®) to treat systemic autoimmune diseases (other than rheumatoid arthritis)
Pages S94-S99
http://www.sciencedirect.com/science?_ob=GatewayURL&_method=citationSearch&_urlVersion=4&_origin=SDVIALERTASCII&_version=1&_uoikey=B6W90-4T72RC0-T&md5=233b14cc147cf1bb3f8ec4792cad6558

================================================================================

Send my e-mails in Formatted text (HTML).
http://www.sciencedirect.com/science/account

If you would like to modify or remove your alerts, click on the link below
http://www.sciencedirect.com/science/alerts

If you have questions about this or other features of ScienceDirect, please access the ScienceDirect Info Site at
http://www.info.sciencedirect.com

----------------------------------------------------------------------------------------------------------------------------------------------------------------

This email has been sent to you by ScienceDirect, a division of Elsevier B.V., Radarweg 29, 1043 NX Amsterdam, The Netherlands, Tel. +31 20 485 3911.

ScienceDirect respects your privacy and does not disclose, rent or sell your personal information to any non-affiliated third parties without your consent, except as may be stated in the ScienceDirect online privacy policy.
http://www.sciencedirect.com/science/privacy

By using email or alert services, you are agreeing to abide by the ScienceDirect Terms and Conditions.
http://www.sciencedirect.com/science/termsandcond

To unsubscribe to alert services, please go to the Alerts page.
http://www.sciencedirect.com/science/alerts

Copyright (C) 2008 ScienceDirect.  All rights reserved.  Any unauthorized use, reproduction, or transfer of this message or its contents, in any medium, is strictly prohibited.  ScienceDirect(R) is a registered trademark of Elsevier B.V.

Delivery Job ID: 1928:168037066:1926:143677612